https://www.hopkinsmedicine.org/psychiatry/research/psychedelics-research
The Johns Hopkins Center for Psychedelic and Consciousness Research is leading the way in exploring innovative treatments using psilocybin.
Previous
Previous
Psilocybin, in 10mg or 25mg doses, has no short- or long-term detrimental effects in healthy people by Kings College London
Next
Next